RxSight, Inc. (RXST) Tops Q4 EPS by 23c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St set for lower open as Big Tech earnings rekindle AI spending worries, oil jumps
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Dollar hits fresh 40-year high versus yen, edges higher against euro
RxSight Inc. (RXST) PT Raised to $64 at Needham, '4Q23 Showed Solid Revenue Growth And Margin Improvement'
February 29, 2024 5:18 AM ESTNeedham analyst David Saxon raised the price target on RxSight Inc. (NASDAQ: RXST) to $64.00 (from $53.00) while maintaining a Buy rating.
The analyst comments "RXST's 4Q23 revenue was in line with its preannouncement (see here) and management reiterated its revenue guidance. Given our... More
